Ancora Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.75K | Sell |
48
-17
| -26% | -$1.33K | ﹤0.01% | 1518 |
|
|
2025
Q1 | $4.75K | Sell |
65
-46
| -41% | -$3.36K | ﹤0.01% | 1416 |
|
|
2024
Q4 | $8.25K | Buy |
111
+46
| +71% | +$3.42K | ﹤0.01% | 1351 |
|
|
2024
Q3 | $4.32K | Buy |
65
+3
| +5% | +$199 | ﹤0.01% | 1437 |
|
|
2024
Q2 | $5.77K | Hold |
62
| – | – | ﹤0.01% | 1374 |
|
|
2024
Q1 | $5.97K | Hold |
62
| – | – | ﹤0.01% | 1376 |
|
|
2023
Q4 | $4.76K | Sell |
62
-290
| -82% | -$22.3K | ﹤0.01% | 1356 |
|
|
2023
Q3 | $24.4K | Buy |
352
+290
| +468% | +$20.1K | ﹤0.01% | 1063 |
|
|
2023
Q2 | $5.89K | Buy |
62
+17
| +38% | +$1.62K | ﹤0.01% | 1327 |
|
|
2023
Q1 | $3.72K | Hold |
45
| – | – | ﹤0.01% | 1410 |
|
|
2022
Q4 | $3K | Hold |
45
| – | – | ﹤0.01% | 1501 |
|
|
2022
Q3 | $4K | Hold |
45
| – | – | ﹤0.01% | 1635 |
|
|
2022
Q2 | $4K | Hold |
45
| – | – | ﹤0.01% | 1743 |
|
|
2022
Q1 | $5K | Sell |
45
-6
| -12% | -$667 | ﹤0.01% | 1908 |
|
|
2021
Q4 | $7K | Buy |
+51
| New | +$7K | ﹤0.01% | 1910 |
|
|
2021
Q3 | – | Sell |
-51
| Closed | -$5K | – | 2204 |
|
|
2021
Q2 | $5K | Buy |
+51
| New | +$5K | ﹤0.01% | 1660 |
|
|
2021
Q1 | – | Sell |
-105
| Closed | -$10K | – | 1718 |
|
|
2020
Q4 | $10K | Buy |
105
+50
| +91% | +$4.76K | ﹤0.01% | 1173 |
|
|
2020
Q3 | $4K | Buy |
+55
| New | +$4K | ﹤0.01% | 1226 |
|
|
2018
Q4 | – | Sell |
-72
| Closed | -$4K | – | 787 |
|
|
2018
Q3 | $4K | Buy |
+72
| New | +$4K | ﹤0.01% | 1264 |
|
|
2017
Q1 | – | Sell |
-1,851
| Closed | -$58K | – | 751 |
|
|
2016
Q4 | $58K | Buy |
+1,851
| New | +$58K | ﹤0.01% | 751 |
|